Background Favipiravir possesses high utility for treating patients with COVID-19. However,
research examining the efficacy and safety of favipiravir for patients with COVID-19 is …

Objectives This study aimed to evaluate the efficacy and adverse events of favipiravir in
patients with COVID-19. Methods Our protocol was registered on PROSPERO …

Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …

A conjugated system was synthesized from reduced graphene quantum dot (rGQD) and
hemin for the selective detection of favipiravir (Fav), an antiviral drug that has come into …

Favipiravir is one of the most used antiviral agents for the treatment of coronavirus disease
2019 infection in many countries, including Thailand. This study aimed to investigate the …

Objective The safety profile of favipiravir in patients with severe renal impairment has not
been investigated and available data are insufficient. The study aimed to compare the …

Favipiravir, a selective RNA polymerase inhibitor agent, is an antiviral drug currently used
effectively in treating pandemic diseases such as Covid-19. The present study aims to …

Purpose: Favipiravir (FAV) used against COVID-19 is an antiviral drug that causes adverse
reactions, such as hyperuricaemia, liver damage, and hematopoetic toxicity. The aim of the …

Существуют экспериментальные и клинические данные касательно активности
фавипиравира в отношении вируса SARS-CoV-2. Имеются сведения о значительной …

Мировой опыт клинического применения фавипиравира весьма ограничен. Его
безопасность требует дальнейшего изучения. Принципиально значимо …